Mettler-Toledo International Inc. Excess Tax Benefit from Share-based Compensation, Financing Activities
Mettler-Toledo International Inc. (MTD) reported Excess Tax Benefit from Share-based Compensation, Financing Activities of $17.20 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-03.
Discontinued › Notes › Compensation Related Costs
us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities · last filed 2017-11-03
- Mettler-Toledo International Inc. excess tax benefit from share-based compensation, financing activities for the quarter ending 2017-09-30 was $6.00M, a 0.23% decline year-over-year.
- Mettler-Toledo International Inc. excess tax benefit from share-based compensation, financing activities for the quarter ending 2016-12-31 was $514.00K, a 95.53% decline year-over-year.
- Mettler-Toledo International Inc. excess tax benefit from share-based compensation, financing activities for the quarter ending 2016-09-30 was $6.01M, a 4195.71% increase year-over-year.
- Mettler-Toledo International Inc. excess tax benefit from share-based compensation, financing activities for the quarter ending 2016-06-30 was $5.35M, a 538.83% increase year-over-year.
- Mettler-Toledo International Inc. excess tax benefit from share-based compensation, financing activities for fiscal 2016 was $17.68M, a 36.75% increase from fiscal 2015.
- Mettler-Toledo International Inc. excess tax benefit from share-based compensation, financing activities for fiscal 2015 was $12.93M, a 263.48% increase from fiscal 2014.
- Mettler-Toledo International Inc. excess tax benefit from share-based compensation, financing activities for fiscal 2014 was $3.56M, a 92.58% increase from fiscal 2013.
- Mettler-Toledo International Inc. excess tax benefit from share-based compensation, financing activities for fiscal 2013 was $1.85M, a 80.28% decline from fiscal 2012.
| Period end | Excess Tax Benefit from Share-based Compensation, Financing Activities 3 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 6 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 9 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 12 month |
|---|---|---|---|---|
| 2017-09-30 | $6.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $17.20M 10-Q · filed 2017-11-03 | ||
| 2017-06-30 | $11.20M 10-Q · filed 2017-07-28 | |||
| 2016-12-31 | $514.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02 | $6.53M derived: sum of 2 quarters · filed 2017-02-02 | $11.88M derived: sum of 3 quarters · filed 2017-02-02 | $17.68M 10-K · filed 2017-02-02 |
| 2016-09-30 | $6.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $11.36M derived: sum of 2 quarters · filed 2016-11-04 | $17.17M 10-Q · filed 2016-11-04 | $28.68M derived: sum of 4 quarters · filed 2017-02-02 |
| 2016-06-30 | $5.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $11.15M 10-Q · filed 2016-07-29 | $22.66M derived: sum of 3 quarters · filed 2017-02-02 | $22.80M derived: sum of 4 quarters · filed 2017-02-02 |
| 2016-03-31 | $5.80M 10-Q · filed 2016-05-06 | $17.32M derived: sum of 2 quarters · filed 2017-02-02 | $17.46M derived: sum of 3 quarters · filed 2017-02-02 | $18.29M derived: sum of 4 quarters · filed 2017-02-02 |
| 2015-12-31 | $11.51M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02 | $11.65M derived: sum of 2 quarters · filed 2017-02-02 | $12.49M derived: sum of 3 quarters · filed 2017-02-02 | $12.93M 10-K · filed 2017-02-02 |
| 2015-09-30 | $140.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $977.00K derived: sum of 2 quarters · filed 2016-11-04 | $1.42M 10-Q · filed 2016-11-04 | -$5.48M derived: sum of 4 quarters · filed 2017-02-02 |
| 2015-06-30 | $837.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $1.28M 10-Q · filed 2016-07-29 | -$5.62M derived: sum of 3 quarters · filed 2017-02-02 | -$4.73M derived: sum of 4 quarters · filed 2017-02-02 |
| 2015-03-31 | $441.00K 10-Q · filed 2016-05-06 | -$6.46M derived: sum of 2 quarters · filed 2017-02-02 | -$5.57M derived: sum of 3 quarters · filed 2017-02-02 | -$497.00K derived: sum of 4 quarters · filed 2017-02-02 |
| 2014-12-31 | -$6.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02 | -$6.01M derived: sum of 2 quarters · filed 2017-02-02 | -$938.00K derived: sum of 3 quarters · filed 2017-02-02 | $3.56M 10-K · filed 2017-02-02 |
| 2014-09-30 | $890.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $5.96M derived: sum of 2 quarters · filed 2015-11-06 | $10.46M 10-Q · filed 2015-11-06 | $11.74M derived: sum of 4 quarters · filed 2016-02-04 |
| 2014-06-30 | $5.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | $9.57M 10-Q · filed 2015-07-31 | $10.85M derived: sum of 3 quarters · filed 2016-02-04 | $10.90M derived: sum of 4 quarters · filed 2016-02-04 |
| 2014-03-31 | $4.50M 10-Q · filed 2015-05-08 | $5.78M derived: sum of 2 quarters · filed 2016-02-04 | $5.82M derived: sum of 3 quarters · filed 2016-02-04 | $6.09M derived: sum of 4 quarters · filed 2016-02-04 |
| 2013-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-04 | $1.33M derived: sum of 2 quarters · filed 2016-02-04 | $1.59M derived: sum of 3 quarters · filed 2016-02-04 | $1.85M 10-K · filed 2016-02-04 |
| 2013-09-30 | $46.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $309.00K derived: sum of 2 quarters · filed 2014-11-07 | $565.00K 10-Q · filed 2014-11-07 | $9.43M derived: sum of 4 quarters · filed 2015-02-06 |
| 2013-06-30 | $263.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-25 | $519.00K 10-Q · filed 2014-07-25 | $9.38M derived: sum of 3 quarters · filed 2015-02-06 | $9.54M derived: sum of 4 quarters · filed 2015-02-06 |
| 2013-03-31 | $256.00K 10-Q · filed 2014-05-09 | $9.12M derived: sum of 2 quarters · filed 2015-02-06 | $9.28M derived: sum of 3 quarters · filed 2015-02-06 | $9.35M derived: sum of 4 quarters · filed 2015-02-06 |
| 2012-12-31 | $8.86M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-06 | $9.03M derived: sum of 2 quarters · filed 2015-02-06 | $9.09M derived: sum of 3 quarters · filed 2015-02-06 | $9.37M 10-K · filed 2015-02-06 |
| 2012-09-30 | $162.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $226.00K derived: sum of 2 quarters · filed 2013-11-08 | $502.00K 10-Q · filed 2013-11-08 | $6.86M derived: sum of 4 quarters · filed 2014-02-07 |
| 2012-06-30 | $64.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-26 | $340.00K 10-Q · filed 2013-07-26 | $6.69M derived: sum of 3 quarters · filed 2014-02-07 | $8.02M derived: sum of 4 quarters · filed 2014-02-07 |
| 2012-03-31 | $276.00K 10-Q · filed 2013-05-03 | $6.63M derived: sum of 2 quarters · filed 2014-02-07 | $7.96M derived: sum of 3 quarters · filed 2014-02-07 | $10.54M derived: sum of 4 quarters · filed 2014-02-07 |
| 2011-12-31 | $6.35M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-07 | $7.68M derived: sum of 2 quarters · filed 2014-02-07 | $10.27M derived: sum of 3 quarters · filed 2014-02-07 | $12.61M 10-K · filed 2014-02-07 |
| 2011-09-30 | $1.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $3.91M derived: sum of 2 quarters · filed 2012-11-02 | $6.26M 10-Q · filed 2012-11-02 | $11.87M derived: sum of 4 quarters · filed 2013-02-08 |
| 2011-06-30 | $2.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-27 | $4.93M 10-Q · filed 2012-07-27 | $10.54M derived: sum of 3 quarters · filed 2013-02-08 | $11.23M derived: sum of 4 quarters · filed 2013-02-08 |
| 2011-03-31 | $2.35M 10-Q · filed 2012-05-04 | $7.95M derived: sum of 2 quarters · filed 2013-02-08 | $8.65M derived: sum of 3 quarters · filed 2013-02-08 | $10.44M derived: sum of 4 quarters · filed 2013-02-08 |
| 2010-12-31 | $5.61M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-08 | $6.30M derived: sum of 2 quarters · filed 2013-02-08 | $8.10M derived: sum of 3 quarters · filed 2013-02-08 | $9.02M 10-K · filed 2013-02-08 |
| 2010-09-30 | $692.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $2.49M derived: sum of 2 quarters · filed 2011-11-04 | $3.41M 10-Q · filed 2011-11-04 | $4.94M derived: sum of 4 quarters · filed 2012-02-13 |
| 2010-06-30 | $1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-01 | $2.72M 10-Q · filed 2011-08-01 | $4.25M derived: sum of 3 quarters · filed 2012-02-13 | $4.65M derived: sum of 4 quarters · filed 2012-02-13 |
| 2010-03-31 | $920.00K 10-Q · filed 2011-05-05 | $2.45M derived: sum of 2 quarters · filed 2012-02-13 | $2.85M derived: sum of 3 quarters · filed 2012-02-13 | |
| 2009-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-13 | $1.94M derived: sum of 2 quarters · filed 2012-02-13 | $2.14M 10-K · filed 2012-02-13 | |
| 2009-09-30 | $407.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | $609.00K 10-Q · filed 2010-11-05 | ||
| 2009-06-30 | $202.00K 10-Q · filed 2010-07-23 | |||
| 2008-12-31 | $1.61M 10-K · filed 2011-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ILLUMINA, INC. (ILMN) | United States | $41.357B | 32.37 |
| WATERS CORP /DE/ (WAT) | United States | $42.297B | 224.28 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| AGILENT TECHNOLOGIES, INC. (A) | United States | $48.720B | 27.14 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |